To evaluate the safety and efficacy of multi component system (TAMBE device) including GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (Aortic Component; AC) under post-marketing use.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Technical Success
Timeframe: From the initial incision or puncture of the access vessel for the implantation procedure to the closure of the access vessel
Clinical Success
Timeframe: 12 Months
Results related to abdominal branch vessels
Timeframe: 60 Months
Major Adverse Events (MAEs)
Timeframe: 60 Months
Thirty-Day Mortality
Timeframe: 30 Days
Lesion-Related Mortality
Timeframe: 30 Days
Reintervention
Timeframe: 60 Months